Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan;23(1):27-32.

MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia

Haruo Hanyu  1 , Tetsuichi Asano, Hirofumi Sakurai, Yuriko Tanaka, Masaru Takasaki, Kimihiko Abe
Affiliations

MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia

Haruo Hanyu et al. AJNR Am J Neuroradiol. 2002 Jan.

Abstract

Background and purpose: The substantia innominata can be visualized on coronal thin-section T2-weighted MR images. The purpose of this study was to investigate the morphologic changes of the substantia innominata in normal aging by using MR imaging and to determine whether the changes in this structure on MR images were specific to Alzheimer disease (AD).

Methods: The thickness of the substantia innominata was measured on the coronal T2-weighted image obtained through the anterior commissure in 39 healthy control subjects (age range, 25-86 y; mean age, 62 y); 39 patients with AD; and 36 patients with non-AD dementia, including vascular dementia, frontotemporal dementia, and Parkinson disease with dementia.

Results: In the control subjects, the thickness of the substantia innominata significantly decreased with age. Compared with age-matched control subjects, both patients with AD and patients with non-AD dementia had significant atrophy of the substantia innominata. The thickness of the substantia innominata significantly correlated with scores from the Mini-Mental State Examination in patients with AD but not in patients with non-AD dementia.

Conclusion: MR analysis reveals age-related shrinkage of the substantia innominata. Atrophy of the substantia innominata, which reflects degeneration in the nucleus basalis of Meynert, is pronounced both in patients with AD and in those with non-AD dementia. MR imaging features in this structure may not be specific to AD.

PubMed Disclaimer

Figures

F<sc>ig</sc> 1.
Fig 1.
Plot shows the correlation between age and thickness of the substantia innominata in control subjects. The thickness of the substantia innominata significantly decreased with normal aging (y = 3.576 − 0.013x, r = −.86, P < .0001).
F<sc>ig</sc> 2.
Fig 2.
Plots show a significant correlation between MMSE scores and thickness of the substantia innominata in patients with AD but not in those with non-AD dementia. NS = not significant (P > .05).
F<sc>ig</sc> 3.
Fig 3.
Coronal T2-weighted MR images (3000/100/3; section thickness, 3 mm; intersection gap, 0.9 mm; matrix, 256 × 231; field of view, 20 cm) shows the substantia innominata in five subjects (arrows, A–E). A, Image in a 37-year-old healthy female control subject. B, Image in a 70-year-old healthy male control subject shows thinning of the substantia innominata. C, Image in a 67-year-old man with AD shows prominent atrophy of the substantia innominata. D, Image in a 74-year-old man with vascular dementia shows prominent atrophy of the substantia innominata. E, Image in a 64-year-old woman with frontotemporal dementia shows prominent atrophy of the substantia innominata.
See this image and copyright information in PMC

Comment in

References

    1. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122–126 - PubMed
    1. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237–1239 - PubMed
    1. Sasaki M, Ehara S, Tamakawa Y, et al MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary study. AJNR Am J Neuroradiol 1995;16:2001–2007 - PMC - PubMed
    1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944 - PubMed
    1. Hachinski VC, Iliff LD, Zilhka E, et al Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637 - PubMed